• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素防治口腔黏膜下纤维化的机制及临床应用研究进展

Mechanism of curcumin in the prevention and treatment of oral submucosal fibrosis and progress in clinical application research.

作者信息

She Rong, Xu Pu

机构信息

Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, 570208, China.

出版信息

BDJ Open. 2024 Oct 25;10(1):82. doi: 10.1038/s41405-024-00268-7.

DOI:10.1038/s41405-024-00268-7
PMID:39455570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512022/
Abstract

INTRODUCTION

Oral submucosal fibrosis is a potentially life-threatening oral disease that significantly impacts physiological functions such as speech and swallowing while also diminishing the quality of life for patients. Currently, the mainstream treatment for oral submucosal fibrosis in clinical practice involves invasive glucocorticoid drugs such as injection therapy. However, this method often leads to intraoperative pain, anxiety, fear, and poor medical experience due to associated side effects.

METHODS

There is an urgent need to actively explore new drugs and relatively noninvasive approaches for the treatment of oral submucosal fibrosis in order to enhance patients' medical experience and compliance. This has become a focal point of attention in clinical research. After conducting an extensive literature search, it was discovered that curcumin, a natural polyphenolic compound, exhibits potent anti-tumor, anti-inflammatory, antioxidant, anti-metastatic and anti-angiogenic properties. Moreover, curcumin holds significant clinical potential in the prevention and treatment of various diseases such as oral submucosal fibrosis.

CONCLUSION

This review presents a comprehensive elaboration encompassing the action mechanisms, biological activity, potential applications, and clinical characteristics of curcumin in the management of oral submucosal fibrosis, aiming to provide diagnostic insights and novel therapeutic perspectives for its prevention and treatment.

摘要

引言

口腔黏膜下纤维化是一种潜在威胁生命的口腔疾病,会严重影响言语和吞咽等生理功能,同时降低患者的生活质量。目前,临床实践中治疗口腔黏膜下纤维化的主流方法包括使用注射疗法等侵入性糖皮质激素药物。然而,由于相关副作用,这种方法常常导致术中疼痛、焦虑、恐惧以及较差的就医体验。

方法

迫切需要积极探索治疗口腔黏膜下纤维化的新药和相对无创的方法,以提高患者的就医体验和依从性。这已成为临床研究的关注焦点。在进行广泛的文献检索后,发现姜黄素这种天然多酚化合物具有强大的抗肿瘤、抗炎、抗氧化、抗转移和抗血管生成特性。此外,姜黄素在预防和治疗口腔黏膜下纤维化等多种疾病方面具有显著的临床潜力。

结论

本综述全面阐述了姜黄素在口腔黏膜下纤维化管理中的作用机制、生物活性、潜在应用和临床特征,旨在为其预防和治疗提供诊断见解和新的治疗视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bb4/11512022/7f24ce4ed498/41405_2024_268_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bb4/11512022/198f5673a703/41405_2024_268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bb4/11512022/7f24ce4ed498/41405_2024_268_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bb4/11512022/198f5673a703/41405_2024_268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bb4/11512022/7f24ce4ed498/41405_2024_268_Fig2_HTML.jpg

相似文献

1
Mechanism of curcumin in the prevention and treatment of oral submucosal fibrosis and progress in clinical application research.姜黄素防治口腔黏膜下纤维化的机制及临床应用研究进展
BDJ Open. 2024 Oct 25;10(1):82. doi: 10.1038/s41405-024-00268-7.
2
Curcumin relieves the arecoline-induced fibrosis of oral mucosal fibroblasts via inhibiting HIF-1α/TGF-β/CTGF signaling pathway: an study.姜黄素通过抑制HIF-1α/TGF-β/CTGF信号通路减轻槟榔碱诱导的口腔黏膜成纤维细胞纤维化:一项研究。
Toxicol Res (Camb). 2021 Jun 1;10(3):631-638. doi: 10.1093/toxres/tfab046. eCollection 2021 May.
3
Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.基于氧化应激的血清和唾液标志物探讨姜黄素在癌前病变中的可能作用机制。
J Oral Sci. 2010 Jun;52(2):251-6. doi: 10.2334/josnusd.52.251.
4
Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.姜黄素及其类似物对头颈部癌症的作用:从药物递送到分子机制。
Phytomedicine. 2023 Oct;119:154986. doi: 10.1016/j.phymed.2023.154986. Epub 2023 Jul 21.
5
A Comparative Study to Evaluate Efficacy of Curcumin and Aloe Vera Gel along with Oral Physiotherapy in the Management of Oral Submucous Fibrosis: A Randomized Clinical Trial.姜黄素和芦荟凝胶联合口腔物理疗法治疗口腔黏膜下纤维化的疗效比较研究:一项随机临床试验。
Asian Pac J Cancer Prev. 2021 Feb 1;22(S1):107-112. doi: 10.31557/APJCP.2021.22.S1.107.
6
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
7
Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.姜黄素通过抑制 LTBP2/NF-κB 轴缓解槟榔碱诱导的口腔黏膜下纤维化。
Oral Dis. 2024 May;30(4):2314-2324. doi: 10.1111/odi.14656. Epub 2023 Jun 29.
8
Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis.天然药物蒙古黄芪治疗心肌纤维化的研究进展。
J Ethnopharmacol. 2023 Apr 6;305:116128. doi: 10.1016/j.jep.2022.116128. Epub 2023 Jan 6.
9
Curcumin: a boon to colonic diseases.姜黄素:结肠疾病的福音。
Curr Drug Targets. 2013 Sep;14(10):1210-8. doi: 10.2174/13894501113149990168.
10
A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.一项评估番茄红素和姜黄素对口腔黏膜下纤维化患者疗效的比较研究:一项随机临床试验。
Indian J Dent Res. 2018 May-Jun;29(3):303-312. doi: 10.4103/ijdr.IJDR_551_16.

引用本文的文献

1
Wound treatment with curcumin prevents hypertrophic scarring and promotes remodeling by inhibiting fibroblast activation and regulating collagen deposition.姜黄素用于伤口治疗可通过抑制成纤维细胞活化和调节胶原蛋白沉积来预防瘢痕疙瘩形成并促进重塑。
Arch Dermatol Res. 2025 May 17;317(1):767. doi: 10.1007/s00403-025-04271-2.

本文引用的文献

1
Curcumin in the treatment of oral submucous fibrosis: a systematic review and meta-analysis of randomized controlled trials.姜黄素治疗口腔黏膜下纤维性变的系统评价和荟萃分析:随机对照试验研究。
Int J Oral Maxillofac Surg. 2024 Mar;53(3):239-250. doi: 10.1016/j.ijom.2023.11.005. Epub 2023 Dec 5.
2
Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.姜黄素及其类似物在非小细胞肺癌治疗中的应用:挑战与展望。
Biomolecules. 2022 Nov 4;12(11):1636. doi: 10.3390/biom12111636.
3
Utility of Intravenous Curcumin Nanodelivery Systems for Improving Pharmacokinetics and Anticancer Pharmacodynamics.
静脉注射姜黄素纳米递药系统提高药代动力学和抗癌药效学的效用。
Mol Pharm. 2022 Sep 5;19(9):3057-3074. doi: 10.1021/acs.molpharmaceut.2c00455. Epub 2022 Aug 16.
4
Immunomodulatory effects of curcumin in systemic autoimmune diseases.姜黄素在系统性自身免疫性疾病中的免疫调节作用。
Phytother Res. 2022 Apr;36(4):1616-1632. doi: 10.1002/ptr.7417. Epub 2022 Mar 18.
5
The nanocomposites designs of phytomolecules from medicinal and aromatic plants: promising anticancer-antiviral applications.药用和芳香植物中植物分子的纳米复合材料设计:有前景的抗癌抗病毒应用。
Beni Suef Univ J Basic Appl Sci. 2022;11(1):17. doi: 10.1186/s43088-022-00198-z. Epub 2022 Jan 29.
6
Immunopathogenesis of oral submucous fibrosis by chewing the areca nut.嚼食槟榔导致口腔黏膜下纤维性变的免疫发病机制。
J Leukoc Biol. 2022 Feb;111(2):469-476. doi: 10.1002/JLB.3MR0521-763RR. Epub 2021 Jun 14.
7
Areca Nut Chewing: Initiation, Addiction, and Harmful Effects Emphasizing the Barriers and Importance of Cessation.嚼槟榔:起始、成瘾及有害影响,强调戒除的障碍和重要性。
J Addict. 2021 Jun 3;2021:9967097. doi: 10.1155/2021/9967097. eCollection 2021.
8
Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review.姜黄素纳米颗粒在乳腺癌治疗中的疗效与毒性:一项系统综述
Front Oncol. 2021 Mar 9;11:612903. doi: 10.3389/fonc.2021.612903. eCollection 2021.
9
The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.结缔组织生长因子在口腔黏膜下纤维性变及其恶性转化发病机制中的作用——免疫组织化学研究。
Head Neck Pathol. 2021 Sep;15(3):817-830. doi: 10.1007/s12105-020-01270-9. Epub 2021 Feb 5.
10
A clinicobiochemical evaluation of curcumin as gel and as buccal mucoadhesive patches in the management of oral submucous fibrosis.姜黄素凝胶和颊黏膜黏附贴片治疗口腔黏膜下纤维性变的临床生物化学评价。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Apr;131(4):428-434. doi: 10.1016/j.oooo.2020.12.020. Epub 2020 Dec 31.